Literature DB >> 12116230

Prevalence of the fragile X syndrome in African-Americans.

Dana C Crawford1, Kellen L Meadows, James L Newman, Lisa F Taft, Elizabeth Scott, Mary Leslie, Lisa Shubek, Patricia Holmgreen, Marshalyn Yeargin-Allsopp, Coleen Boyle, Stephanie L Sherman.   

Abstract

Since the development of a molecular diagnosis for the fragile X syndrome in the early 1990s, several population-based studies in Caucasians of mostly northern European descent have established that the prevalence is probably between one in 6,000 to one in 4,000 males in the general population. Reports of increased or decreased prevalence of the fragile X syndrome exist for a few other world populations; however, many of these are small and not population-based. We present here the final results of a 4-year study in the metropolitan area of Atlanta, Georgia, establishing the prevalence of the fragile X syndrome and the frequency of CGG repeat variants in a large Caucasian and African-American population. Results demonstrate that one-quarter to one-third of the children identified with the fragile X syndrome attending Atlanta public schools are not diagnosed before the age of 10 years. Also, a revised prevalence for the syndrome revealed a higher point estimate for African-American males (1/2,545; 95% CI: 1/5,208-1/1,289) than reported previously, although confidence intervals include the prevalence estimated for Caucasians from this (1/3,717; 95% CI: 1/7,692-1/1,869) and other studies. Further population-based studies in diverse populations are necessary to explore the possibility that the prevalence of the fragile X syndrome differs among world populations. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12116230     DOI: 10.1002/ajmg.10427

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  60 in total

1.  Diagnosis of fragile X syndrome: a qualitative study of African American families.

Authors:  Jeannie Visootsak; Krista Charen; Julia Rohr; Emily Allen; Stephanie Sherman
Journal:  J Genet Couns       Date:  2011-12-02       Impact factor: 2.537

2.  Identification of expanded alleles of the FMR1 gene among high-risk population in Indonesia by using blood spot screening.

Authors:  Tri Indah Winarni; Agustini Utari; Farmaditya E P Mundhofir; Tzuhan Tong; Blythe Durbin-Johnson; Sultana M H Faradz; Flora Tassone
Journal:  Genet Test Mol Biomarkers       Date:  2011-10-11

3.  Living with genetic risk: effect on adolescent self-concept.

Authors:  Allyn McConkie-Rosell; Gail A Spiridigliozzi; Elizabeth Melvin; Deborah V Dawson; Ave M Lachiewicz
Journal:  Am J Med Genet C Semin Med Genet       Date:  2008-02-15       Impact factor: 3.908

4.  FMR1 gene mutations in patients with fragile X syndrome and obligate carriers: 30 years of experience in Chile.

Authors:  Lorena Santa María; Solange Aliaga; Víctor Faundes; Paulina Morales; Ángela Pugin; Bianca Curotto; Paula Soto; M Ignacia Peña; Isabel Salas; M Angélica Alliende
Journal:  Genet Res (Camb)       Date:  2016-06-28       Impact factor: 1.588

5.  The fragile X prevalence paradox.

Authors:  Paul J Hagerman
Journal:  J Med Genet       Date:  2008-04-15       Impact factor: 6.318

6.  High-risk fragile x screening in Guatemala: use of a new blood spot polymerase chain reaction technique.

Authors:  Jennifer Yuhas; Paulina Walichiewicz; Ruiqin Pan; Wenting Zhang; E Melina Casillas; Randi J Hagerman; Flora Tassone
Journal:  Genet Test Mol Biomarkers       Date:  2009-12

7.  FMR1 CGG Repeats: Reference Levels and Race-Ethnic Variation in Women With Normal Fertility (Study of Women's Health Across the Nation).

Authors:  Lisa M Pastore; Ani Manichaikul; Xin Q Wang; Joel S Finkelstein
Journal:  Reprod Sci       Date:  2016-02-22       Impact factor: 3.060

8.  Contrast detection in infants with fragile X syndrome.

Authors:  F Farzin; D Whitney; R J Hagerman; S M Rivera
Journal:  Vision Res       Date:  2008-05-23       Impact factor: 1.886

Review 9.  Fragile X: a family of disorders.

Authors:  Weerasak Chonchaiya; Andrea Schneider; Randi J Hagerman
Journal:  Adv Pediatr       Date:  2009

10.  The efficacy of melatonin for sleep problems in children with autism, fragile X syndrome, or autism and fragile X syndrome.

Authors:  Juthamas Wirojanan; Sebastien Jacquemont; Rafael Diaz; Susan Bacalman; Thomas F Anders; Randi J Hagerman; Beth L Goodlin-Jones
Journal:  J Clin Sleep Med       Date:  2009-04-15       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.